Veeva Systems Reports 18% Revenue Growth to $928 Million in Q2 Fiscal 2027

Veeva Systems Inc. reported strong financial performance for the second quarter of fiscal 2027, with total revenues reaching $928 million, a 18% increase from $789 million in the same period last year. Subscription revenues, which accounted for approximately 83% of total revenues, rose to $767 million, up 16% year-over-year. The company also saw a significant increase in professional services and other revenues, which grew by 24% to $161 million. For the first half of the fiscal year, total revenues amounted to $1.81 billion, compared to $1.55 billion in the prior year, reflecting a 17% increase.

The company’s net income for the quarter was $273 million, or $1.66 per diluted share, compared to $200 million, or $1.19 per diluted share, in the same quarter last year. For the six months ended July 31, 2026, net income was $534 million, up from $428 million in the prior year. The increase in profitability was attributed to higher revenues and effective cost management, despite a rise in operating expenses, which totaled $421 million for the quarter, up from $398 million a year earlier.

Strategically, Veeva completed the acquisition of Rise Healthcare Tech, Inc. (Ostro) for $90 million, enhancing its engagement platform capabilities in the life sciences sector. The company continues to focus on expanding its product offerings, particularly in the areas of artificial intelligence and cloud solutions tailored for the life sciences industry. As of July 31, 2026, Veeva served 1,552 customers, an increase from 1,477 a year earlier, with a notable rise in customer engagement metrics.

Operationally, Veeva reported a strong customer retention rate, with a significant portion of its revenue derived from existing customers expanding their use of Veeva's solutions. The company also noted a geographic revenue distribution of 60% from North America, 29% from Europe, and 11% from Asia Pacific, indicating a balanced global presence. Employee headcount increased to support growth initiatives, with a focus on enhancing research and development capabilities.

Looking ahead, Veeva anticipates continued revenue growth driven by increased adoption of its cloud solutions and ongoing investments in product development. The company remains optimistic about its market position, despite potential challenges from economic fluctuations and competitive pressures in the life sciences sector. Veeva's management emphasized their commitment to maintaining strong operational performance and delivering value to shareholders through strategic investments and a disciplined approach to cost management.